Victor Nurcombe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Victor Nurcombe has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
S.M. Cool
3 shared publicationsL. Ling
2 shared publicationsT.H. Goh
2 shared publicationsA. Van Wijnen
1 shared publication- Anne-Sophie Vercoutter-Edouart
Univ. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France
1 shared publication Benoni Boilly
1 shared publication
Latest Publications
- 1 July 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50, S123
509: Fibroblast growth factor receptor 1 controls cancer cell survival via ERK signaling
- 1 July 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50, S123
509: Fibroblast growth factor receptor 1 controls cancer cell survival via ERK signaling
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S123
1095 POSTER Growth Factor Receptor-targeted Therapy for Cancer
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S123
1095 POSTER Growth Factor Receptor-targeted Therapy for Cancer
- 1 January 2001
- Vol. 61 (1) , 76-80
Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
The class of molecular chaperones known as 14-3-3 is involved in the control of cellular growth by virtue of its apparent regulation of various signaling pathways, including the Raf/mitogen-activated protein kinase pathway. In breast cancer cells, the sigma form of 14-3-3 has been shown to interact with cyclin-dependent kinases and to control the rate of entry into mitosis. To test for a direct role for 14-3-3 in breast epithelial cell neoplasia, we have quantitated 14-3-3 protein levels using a proteomic approach based on two-dimensional electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF). We show here that 14-3-3sigma protein is strongly down-regulated in the prototypic breast cancer cell lines MCF-7 and MDA-MB-231 and in primary breast carcinomas as compared with normal breast epithelial cells. In contrast, levels of the alpha, beta, delta, or zeta isoforms of 14-3-3 were the same in both normal and transformed cells. The data support the idea that 14-3-3sigma is involved in the neoplastic transition of breast epithelial cells by virtue of its role as a tumor suppressor; as such, it may constitute a robust marker with clinical efficacy for this pathology.
- 1 January 2001
- Vol. 61 (1) , 76-80
Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
The class of molecular chaperones known as 14-3-3 is involved in the control of cellular growth by virtue of its apparent regulation of various signaling pathways, including the Raf/mitogen-activated protein kinase pathway. In breast cancer cells, the sigma form of 14-3-3 has been shown to interact with cyclin-dependent kinases and to control the rate of entry into mitosis. To test for a direct role for 14-3-3 in breast epithelial cell neoplasia, we have quantitated 14-3-3 protein levels using a proteomic approach based on two-dimensional electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF). We show here that 14-3-3sigma protein is strongly down-regulated in the prototypic breast cancer cell lines MCF-7 and MDA-MB-231 and in primary breast carcinomas as compared with normal breast epithelial cells. In contrast, levels of the alpha, beta, delta, or zeta isoforms of 14-3-3 were the same in both normal and transformed cells. The data support the idea that 14-3-3sigma is involved in the neoplastic transition of breast epithelial cells by virtue of its role as a tumor suppressor; as such, it may constitute a robust marker with clinical efficacy for this pathology.
- Open Access
- 1 September 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (39) , 30009-30018
The Proliferative and Migratory Activities of Breast Cancer Cells Can Be Differentially Regulated by Heparan Sulfates
- 1 September 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (39) , 30009-30018
Open AccessThe Proliferative and Migratory Activities of Breast Cancer Cells Can Be Differentially Regulated by Heparan Sulfates